Qiagen and its subsidiaries are currently working on the development of 131 products that fall under the In Vitro Diagnostics, Healthcare IT markets. GlobalData’s report Qiagen Medical Device Development provides an overview of the company’s pipeline landscape and offers detailed analysis of its products in development. Buy the report here.
The company’s devices in development are either in the late stage of development or are in an early development stage.
The main research and development focus of Qiagen is on infectious diseases, followed by cancer, respiratory tract diseases, nervous system diseases, digestive system diseases, genetic disorders, immune system diseases, cardiovascular diseases and women's health.